Ifosfamide (IFO) in the treatment of metastatic hormone refractory prostate cancer

被引：0
|
作者：
KellokumpuLehtinen, P
Lehtinen, T
Tammela, T
机构：
[1] TAMPERE UNIV HOSP,DEPT ONCOL,TAMPERE,FINLAND
[2] TAMPERE UNIV HOSP,DEPT UROL,TAMPERE,FINLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [1] TREATMENT IN METASTATIC PROSTATE CANCER WITH HORMONE REFRACTORY
    Vitello, S.
    Vacirca, F.
    Triglia, E.
    Giarratano, G.
    [J]. EJC SUPPLEMENTS, 2008, 6 (14): : 126 - 126
  • [2] Docetaxel re-treatment for metastatic hormone refractory prostate cancer
    Ansari, J.
    Hussain, S. A.
    Zarkar, A.
    Bliss, J.
    Tanguay, J. S.
    Glaholm, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] HORMONE REFRACTORY METASTATIC PROSTATE-CANCER
    STERNBERG, CN
    [J]. ANNALS OF ONCOLOGY, 1992, 3 (05) : 331 - 335
  • [4] State-of-the-art treatment of metastatic hormone-refractory prostate cancer
    Goodin, S
    Rao, KV
    DiPaola, RS
    [J]. ONCOLOGIST, 2002, 7 (04): : 360 - 370
  • [5] DocetaxelIn Hormone-Refractory Metastatic Prostate Cancer
    Kate McKeage
    Susan J. Keam
    [J]. Drugs, 2005, 65 : 2287 - 2294
  • [6] Intermittent chemotherapy for metastatic hormone refractory prostate cancer
    Lin, Amy M.
    Ryan, Charles J.
    Small, Eric J.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 61 (03) : 243 - 254
  • [7] Docetaxel in hormone-refractory metastatic prostate cancer
    Oh, WK
    [J]. DRUGS, 2005, 65 (16) : 2296 - 2297
  • [8] A randomised dose-finding phase II study on ifosfamide in metastatic hormone-refractory prostate cancer (HRPC)
    Hervonen, P
    Lehtinen, T
    Tammela, TL
    Kellokumpu-Lehtinen, P
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2002, 21 (02) : 177 - 180
  • [9] A randomized dose-finding phase II study of ifosfamide (IF) in metastatic hormone-refractory prostate cancer (HRPC).
    Hervonen, P
    Lehtinen, T
    Tammela, TLJ
    Kellokumpu-Lehtinen, P
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 76 - 76
  • [10] Salvage chemotherapy for hormone-refractory prostate cancer: Association of Adriamycin and ifosfamide
    Toulmonde, Maud
    Demolis, Pascal
    Houede, Nadine
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (06) : 1005 - 1011
12345